MSF staff in South Africa, KwaZulu-Natal speaking with a Drug Resistant Tuberculosis (DR-TB)patient

South Africa

In South Africa, we respond to disease epidemics and non-communicable disease

In October 2023, in partnership with the Eastern Cape Department of Health, we launched a project to improve the identification and management of non-communicable diseases (NCDs) in the Amathole District, which is MSF's first NCDs project in South Africa. We aim to apply lessons from two decades of working on HIV and tuberculosis (TB) in South Africa to enhance NCD care in rural settings.


 

Our activities in 2023 in South Africa

Data and information from the International Activity Report 2023.

MSF activities in South Africa in 2023 In South Africa, Doctors Without Borders (MSF) launched a project to improve care for patients with non-communicable diseases (NCDs). We also supported the Department of Health’s response to a cholera outbreak.
MSF, Doctors Without Borders, South Africa Activities in 2023

The new project in Butterworth, Eastern Cape province, focuses on improving screening, diagnosis, treatment and prevention of NCDs, such as diabetes and hypertension, through advocacy, research, health promotion, training and mentorship of community healthcare workers (CHWs). In collaboration with the Department of Health, we trained CHWs, nurses and community-based organisations, and ran awareness campaigns that reached over 1,500 people in the region.

We also identified medication pick-up points and kickstarted the registration process in consultation with patients, the Department of Health and community-based organisations. Pick-up points are run by private providers who dispense NCD drugs to patients on behalf of the government.

In May, in Hamanskraal, Tshwane city, we supported a cholera intervention by establishing a cholera treatment unit in the community. We also provided technical support to the unit’s infection prevention and control department. In addition, we donated hygiene kits comprising oral rehydration tablets, soap, aqua tabs, buckets and jerry cans, and partnered with other international organisations to train Department of Health staff in all nine provinces of South Africa on cholera readiness.

At the end of 2023, we handed over our Tshwane migrant project to the local authorities and a community-based organisation, after training staff on how to work with undocumented people. Our team had provided access to medical care for migrants and other marginalised groups, and worked to ensure this would continue after our departure.

After 12 years of operations, we closed our HIV and tuberculosis (TB) project in Eshowe, KwaZulu-Natal province. The project’s community-oriented approach helped to increase integrated treatment of HIV, TB, diabetes and hypertension through nine community-based sites, which were successfully handed over to the Department of Health. Many achievements have been made in introducing TB health promotion activities in schools, and we have also shared valuable guidance on integrating drug-resistant TB services into general healthcare services.

 

IN 2023

 
MSF, Doctors Without Borders, TB, cystic fibrosis
Access to medicines

South Africa's patent system encourages profits over lives

Press Release 18 Jul 2023
 
MSF_Protest_At_J&J_Offices_In_SA_MSF288569
Access to medicines

MSF calls again on J&J to withdraw/abandon extended patents on lifesaving TB drug

Latest News 18 Jul 2023
 
MSF, Doctors Without Borders, TB
Tuberculosis

TB medicine deal offers short-term solution, but J&J needs to do more for all affected countries

Press Release 14 Jul 2023
 
MSF, Doctors Without Borders, cholera outbreaks in Southern Africa
Cholera

If we can’t avoid people getting sick from cholera, we must at least avoid them dying from it

Latest News 22 Jun 2023
 
MSB158538_cholera
Cholera

Cholera Treatment Unit supported by MSF plays key role in Hammanskraal cholera response

Latest News 1 Jun 2023
 
Nanyanyiso Baloi holds her treatment regimen for pre-XDR-TB.
Drug-resistant TB

TAC and MSF intervene in a case for a lifesaving cystic fibrosis drug priced at over R5 million

Press Release 10 May 2023